Patent · US Active

Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (CD137)

US11814411B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignees

BIONTECH SE · DE
GENMAB A/S · DK

Inventors

Ugur Sahin · Mainz, DE
Friederike Gieseke · Mainz, DE
Isil Altintas · Utrecht, NL
David Satijn · Utrecht, NL
Paul Parren · Utrecht, NL

Key dates

Filing date	Jan 8, 2021
Grant date	Nov 14, 2023
Priority date	—
Expiry date	Jul 10, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to binding agents binding to receptors of the TNF superfamily, in particular binding agents binding to at least two different receptors of the TNF superfamily, as well as to their use in medicine. The present invention further relates to nucleic acid molecules encoding such binding agents, to cells comprising such nucleic acid molecules and to pharmaceutical compositions and kits.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.